Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Bile Acid Metabolism-Based Integrative Subtyping Reveals CLCA1, UGT2A3, and ZG16 as Indicators of Immune Dysfunction and Adverse Outcomes in Colorectal Cancer

  • By

  • Li Feng

  • Min Wang

  • Xin Li

  • Long Wu

  • DeXin Gu

  • Bin Zhang

  • Peng Zheng

  • Qifeng Yang

  • Ke Wang

  • Gang Mao

  • August 27, 2026

Share

Original Source(s)

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer

  • by Li Feng, Min Wang, Xin Li, Long Wu, DeXin Gu, Bin Zhang, Peng Zheng, Qifeng Yang, Ke Wang, Gang Mao

  • August 27, 2026

Related Content

Retraction Note: Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway

Hepatectomy outperforms microwave ablation for colorectal cancer liver metastases, with anatomical location affecting ablation outcomes

The COVID-19 Pandemic and Changes in Cancer Screening Disparities from 2015 to 2023: An NSHAP Survey Study